We consider transparent disclosure of our environmental, social and governance (ESG) impacts and efforts an important part of how we do business. In the face of global disruption caused by climate change, natural resource scarcity, social volatility and fast-changing technology, what were once considered nonfinancial risks are becoming material and systematic. Companies face increased scrutiny from a host of stakeholders, including customers, investors, employees and policymakers around ESG issues. Takeda is no exception, with growing demand for disclosure from many stakeholders, including investors. We routinely engage with ESG rating organizations and investors to better understand their expectations and reflect their priorities in our business activities and disclosures.
Name of Index or Rating | Company/ Organization | History of Inclusion |
Dow Jones Sustainability Asia Pacific Index | S&P Global | 12th consecutive year |
FTSE4Good Developed Index | FTSE Russell | 17th consecutive year |
MSCI ESG Leaders Index | MSCI | 12th consecutive year |
ISS ESG’s Prime Status | ISS | 3rd consecutive year |
Global 100 Most Sustainable Corporations | Corporate Knights | 2015-2020 |
Access to Medicines Index |
Access to Medicines Foundation |
Ranked 6th overall and led the pharmaceutical industry in Governance of Access |
As of January 2022